Opportunities in smallcaps header image 2

(Exclusive) The Selloff In EDAP Looks Overdone

May 5th, 2020 · No Comments

  • EDAP, developer of promising medical devices for HIFU and ESWL treatments, has been buffeted by hospitals concentrating on treating Covid-19 patients.
  • However, this looks like postponement to us, with little long-term damage to the company’s perspectives, which remain bright.
  • We therefore see the 50%+ correction in the share price as an opportunity.

Source: (Exclusive) The Selloff In EDAP Looks Overdone (NASDAQ:EDAP) | Seeking Alpha

Tags: EDAP